glp-1 for iih medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih Effect of glucagon like peptide-1

These observations suggest that the effects of GLP-1 RAs at the afferent arteriole is in part mediated by NO

22% of those who were told by a doctor that they are overweight or obese report having used GLP-1 medications

For eczema patients, microneedle peptide patches could provide controlled, sustained release directly to affected areas

When to Expect Appetite Changes Initial Effects (1-2 Weeks): Semaglutide GLP-1 begins to show effects relatively quickly, but most users notice significant changes in appetite within the first 1 to 2 weeks

This raises our awareness of never initiating SUs (Sulphonylurea) or Meglitides with once weekly GLP1RAs especially in naive T2DM patients